Literature DB >> 17148758

Sexual dimorphism of ornithine decarboxylase in the mouse adrenal: influence of polyamine deprivation on catecholamine and corticoid levels.

Carmen M Bastida1, Asunción Cremades, Maria T Castells, Andrés J López-Contreras, Carlos López-García, Jesús Sánchez-Mas, Rafael Peñafiel.   

Abstract

Adrenal sexual dimorphism is thought to be important in explaining sex-related differences regarding prevalent diseases and the responses to stress and drugs. We report here that in CD1 mice there is marked sexual dimorphism affecting not only gland size and corticoid hormone secretion but also adrenal ornithine decarboxylase (ODC), polyamine, and catecholamine levels in which testosterone appears to be a major determinant. Our results show that adrenal weight, ODC activity, and corticosterone and aldosterone secretion were higher in female than in male mice and that orchidectomy brought these male parameters closer to the values found in females. mRNA levels of steroidogenic proteins SF-1, Dax-1, steroid 21-hydroxylase, and aldosterone synthase appeared to be slightly higher in female than in male adrenals. Immunocytochemical analysis of adrenal ODC revealed that immunoreactivity was higher in females than in males and was located mainly in the cortical cells, and especially in zona glomerulosa, whereas no sex differences in ODC mRNA levels were observed. These results suggest that sex-associated differences in the expression of ODC in the mouse adrenal gland appear to be related mainly to posttranscriptional mechanisms. Combination treatment of mice with alpha-difluoromethylornithine (a suicide inhibitor of ODC) and a polyamine-deficient diet produced a marked decrease in adrenal polyamine and catecholamine levels and a significant reduction in plasma corticosterone and aldosterone concentrations that were not associated with a decrease in the mRNA levels of steroidogenic proteins. All of these data suggest a relevant role for testosterone, ODC, and polyamines in the mouse adrenal function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17148758     DOI: 10.1152/ajpendo.00316.2006

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  16 in total

Review 1.  Suicide and the polyamine system.

Authors:  Jeffrey A Gross; Gustavo Turecki
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-11       Impact factor: 4.388

2.  Polyamines and suicide risk.

Authors:  G Turecki
Journal:  Mol Psychiatry       Date:  2013-10-29       Impact factor: 15.992

3.  Evidence of altered polyamine concentrations in cerebral cortex of suicide completers.

Authors:  Gary Gang Chen; Laura M Fiori; Luc Moquin; Alain Gratton; Orval Mamer; Naguib Mechawar; Gustavo Turecki
Journal:  Neuropsychopharmacology       Date:  2010-03-03       Impact factor: 7.853

Review 4.  The molecular bases of the suicidal brain.

Authors:  Gustavo Turecki
Journal:  Nat Rev Neurosci       Date:  2014-10-30       Impact factor: 34.870

5.  Endocannabinoid signaling in hypothalamic-pituitary-adrenocortical axis recovery following stress: effects of indirect agonists and comparison of male and female mice.

Authors:  Christopher J Roberts; Kara L Stuhr; Michael J Hutz; Hershel Raff; Cecilia J Hillard
Journal:  Pharmacol Biochem Behav       Date:  2013-12-05       Impact factor: 3.533

6.  Targeted Disruption of YAP and TAZ Impairs the Maintenance of the Adrenal Cortex.

Authors:  Adrien Levasseur; Guillaume St-Jean; Marilène Paquet; Derek Boerboom; Alexandre Boyer
Journal:  Endocrinology       Date:  2017-11-01       Impact factor: 4.736

Review 7.  Implication of the polyamine system in mental disorders.

Authors:  Laura M Fiori; Gustavo Turecki
Journal:  J Psychiatry Neurosci       Date:  2008-03       Impact factor: 6.186

8.  Differential effects of high and low steroidogenic factor-1 expression on CYP11B2 expression and aldosterone production in adrenocortical cells.

Authors:  Ping Ye; Yashuhiro Nakamura; Enzo Lalli; William E Rainey
Journal:  Endocrinology       Date:  2008-10-30       Impact factor: 4.736

9.  Modulation of circadian glucocorticoid oscillation via adrenal opioid-CXCR7 signaling alters emotional behavior.

Authors:  Yuichi Ikeda; Hidetoshi Kumagai; Amber Skach; Makito Sato; Masashi Yanagisawa
Journal:  Cell       Date:  2013-12-05       Impact factor: 41.582

Review 10.  Adrenal cortex renewal in health and disease.

Authors:  Rodanthi Lyraki; Andreas Schedl
Journal:  Nat Rev Endocrinol       Date:  2021-05-19       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.